Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 4 years
- Director since
- 2024
4 years of board service in total across 3 boards, counting each seat separately. Longest: Actuate Therapeutics Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Arbutus Biopharma Corporation May 26, 202695.1%
-
Actuate Therapeutics Inc. May 22, 2025100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Arbutus Biopharma Corporation | Sold back to the company | −17,142 | $5.00 | $85,710 |
| Sep 18, 2026 | Arbutus Biopharma Corporation | Option exercise | +52,533 | $3.34 | $175,460 |
| Sep 18, 2026 | Arbutus Biopharma Corporation | Option exercise | +78,800 | $4.24 | $334,112 |
| Sep 18, 2026 | Arbutus Biopharma Corporation | Shares withheld for tax | −100,508 | $5.07 | $509,576 |
Questions about Roger Sawhney
What boards is Roger Sawhney on?
Roger Sawhney sits on the boards of Actuate Therapeutics Inc., Adlai Nortye Group Ltd. and Arbutus Biopharma Corporation.
How long has Roger Sawhney served on boards?
Our records show at least 4 years of board service across 3 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.